Abstract
We measured serum procalcitonin concentrations in 160 patients suffering from Kawasaki disease. Serum procalcitonin was significantly higher in nonresponders to an initial intravenous immunoglobulin treatment than in responders. A cutoff value of procalcitonin (0.5 ng/mL) for nonresponders showed that the sensitivity was 85% and the accuracy was 64%. Multivariate logistic regression analysis revealed that procalcitonin-positive cases showed the highest risk for nonresponders.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Calcitonin / blood*
-
Calcitonin Gene-Related Peptide
-
Child, Preschool
-
Female
-
Humans
-
Immunoglobulins, Intravenous / therapeutic use
-
Infant
-
Male
-
Mucocutaneous Lymph Node Syndrome / diagnosis
-
Mucocutaneous Lymph Node Syndrome / physiopathology*
-
Mucocutaneous Lymph Node Syndrome / therapy
-
Predictive Value of Tests
-
Prognosis
-
Protein Precursors / blood*
-
Sensitivity and Specificity
-
Severity of Illness Index
Substances
-
CALCA protein, human
-
Immunoglobulins, Intravenous
-
Protein Precursors
-
Calcitonin
-
Calcitonin Gene-Related Peptide